JOURNAL OF CLINICAL SURGERY ›› 2023, Vol. 31 ›› Issue (5): 440-443.doi: 10.3969/j.issn.1005-6483.2023.05.011

Previous Articles     Next Articles

Expression and diagnostic value of miR-144,MALAT1 and SPOCK1 in bladder cancer tissue

  

  1. Department of Urology,Suining Central Hospital,Sichuan,Suining 629000,China
  • Received:2022-09-19 Revised:2022-09-19 Online:2023-05-20 Published:2023-05-20

Abstract: Objective To analyze the expression of miR-144,lung cancer metastasis-associated transcript 1 (MALA T1) and testis proteoglycan (SPOCK1) in bladder cancer tissues and their diagnostic efficacy.Methods A total of 96 bladder cancer patients who were treated in our hospital from January 2018 to January 2021 were selected.Fresh tumor tissue from bladder cancer patients (tumor group) and normal tissue adjacent to the tumor > 2 cm away from the tumor edge (paracancerous group) were collected during surgery.5 mg each.The relative expression levels of miR-144,MALAT1 and SPOCK1 in different tissues were detected by polymerase chain reaction (PCR),and the expressions of miR-144,MALAT1 and SPOCK1 in different pathological features of bladder cancer were analyzed.The ROC curve was drawn to test the diagnostic effect of miR-144,MALAT1 and SPOCK1 on bladder cancer.96 patients underwent surgery + postoperative adjuvant chemotherapy in our hospital,and the patients were followed up by telephone and outpatient followup.Followup ended on January 30,2022,and the expressions of miR-144,MALAT1 and SPOCK1 were compared in patients with different prognosis.Results The relative expressions of MALAT1 and SPOCK1 in the tumor group were significantly higher than those in the paracancerous group,while the relative expression of miR-144 was significantly lower than that in the control group (P<0.05).The expression of miR-144 in stage Ⅲ-Ⅳ patients with lymph node metastasis was significantly lower than that in stage Ⅰ-Ⅱ patients without lymph node metastasis(P<0.05).MALAT1 and SPOCK levels in stage Ⅲ-Ⅳ,poorly differentiated,and lymph node metastasis were significantly higher than those in stage Ⅰ-Ⅱ,moderately and well differentiated,and no lymph node metastasis (P<0.05).The ROC curve was drawn,and the AUC value was calculated.The AUC values of miR-144,MALAT1 and SPOCK1 for the diagnosis of bladder cancer were 0.643 and 0.557,respectively,and the AUC value for the diagnosis of SPOCK1 was 0.717 (95%Cl:0.688-0.845).the highest AUC value was diagnosed with SPOCK1 (P<0.05).Follow-up data showed that 85 of 96 patients had good prognosis and 11 had poor prognosis.The miR-144 in the poor prognosis group was significantly lower than that in the good prognosis group,and MALAT1 and SPOCK1 were significantly higher than those in the good prognosis group (P<0.05).Conclusion The abnormal expression of miR-144,MALAT1 and SPOCK1 in bladder cancer tissue has a certain relationship with the pathological characteristics of patients,and may be used as potential diagnostic markers for bladder cancer.

Key words: bladder cancer, MiR-144, lung cancer metastasis-associated transcript 1, testis proteoglycan, degree of differentiation, pathological features

[1] GUAN Fuyong, WANG Li, WANG Junlin, et al. Risk factors of recurrence in patients with residual tumor after transurethral resection of bladder tumor for non muscular invasive bladder cancer [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(2): 127-131.
[2] CHEN Yongwei, LI Hao, HUANG Li, et al. Effects of neoadjuvant chemotherapy combined with transurethral resection of bladder tumor on tumor diameter,urine BTA level and recurrence rate in patients with bladder cancer [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(2): 152-155.
[3] YAO Baochun, DENG Dayi, FANG Qiang, et al.. Comparison of effect and stress response between laser resection and electro-resection under cystoscopy for non-muscular invasive bladder cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(6): 579-582.
[4] LI Lingrui, SONG Junlong , LIU Hanqing, et al. Genomic alterations and clinicopathological analysis in patients with papillary thyroid carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 222-225.
[5] ZHANG Shun, DING Qiubo, ZHUANG Junlong. 2 cases of immune-related cystitis caused by neoadjuvant immunotherapy for bladder cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 276-279.
[6] LI Yuzhu, XIA Lianjie. Expression of Dickkopfrelated protein 2 in cancer tissues of patients with bladder cancer and its correlation with prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 280-283.
[7] XU Weijie, LI Jinyu, LIN Lianzheng, et al.. Effect of transurethral plasma ERBT on blood loss and oxidative stress factors in patients with NMIBC [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(12): 1187-1190.
[8] . The expression of the cluster of differentiation 74 in tissues of gallbladder cancer and its correlation of the expression of EGFR [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(10): 977-980.
[9] HE Ling, Xu Kun, Ren Ming, et al.. Clinicopathological features and surgical strategy of papillary thyroid carcinoma with coexistent Hashimoto’s thyroiditis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(1): 40-43.
[10] JIANG Xiaoqin, LI Huizhen.. Safety and effectiveness study of simultaneous TURBT and TURP in treatment of non-muscle-invasive bladder cancer patients complicated by benign prostatic hyperplasia [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(9): 872-875.
[11] . Assessment of sexual function of patients with nonmuscle invasive bladder cancer during intravesical treatment [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(4): 372-375.
[12] ZHAO Yubo, LIU Cuilong, WANG Xiyou, et al.. Narrow band imaging combined with green laser in the treatment of non-muscle invasive bladder tumor [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1071-1074.
[13] FENG Qin, LIU Ling, HE Qiying, et al.. The Effects of internet + Self-management program on the continuance the quality of life of patients with bladder cancer undergoing ileum cystostomy [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 971-975.
[14] TAN Wanyan, LI Ningxu.. Expression of MFAP2 in colorectal cancer and its effect on the patient's prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(3): 258-262.
[15] SONG Kun, HU Yingming, JIANG Chengming, et al.. Comparison of clinicopathological features and prognosis of recurrent gastric cancer and gastric cancer recurrence [J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(10): 955-957.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 735 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 737 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 744 .
[4] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 764 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 780 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 783 .
[7] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 787 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 789 .
[9] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 792 .
[10] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 804 .